iuvo BioScience Acquires Promedica International to Expand Ophthalmic Clinical CRO Services

iuvo BioScience, a specialty PROTM (Partner Research Organization) providing preclinical and clinical development services, laboratory services, and scientific consulting services, announces it has acquired Promedica International, a California Corporation (“PMI”), a specialty ophthalmology-focused clinical CRO. The combined organization will support all aspects of ophthalmic clinical research, from front of the eye to back of the eye, leveraging an even larger team of experts with centuries of collective experience in ophthalmology. Backed by private equity firm Ampersand Capital Partners, the combined business is well-positioned for continued growth as it becomes a global leader in delivering end-to-end laboratory, consulting, and clinical development services.

Read the full article: iuvo BioScience Acquires Promedica International to Expand Ophthalmic Clinical CRO Services //

Source: https://www.prweb.com/releases/iuvo-bioscience-acquires-promedica-international-to-expand-ophthalmic-clinical-cro-services-302037906.html

Leave a Comment

Your email address will not be published.

Scroll to Top